Terray says its AI model beats Boltz-2 at binding affinity predictionnews2026-02-12T13:00:16+00:00February 12th, 2026|Endpoints News|
Leash Bio warns of ‘cheating’ AI models on drug-protein predictionsnews2026-02-12T12:00:17+00:00February 12th, 2026|Endpoints News|
Isomorphic claims major advance with new AI drug design enginenews2026-02-10T20:33:26+00:00February 10th, 2026|Endpoints News|
QuantX raises $85M Series B from Lilly, Sanofi Venturesnews2026-02-09T18:26:47+00:00February 9th, 2026|Endpoints News|
Takeda, Iambic sign multiyear R&D deal for AI drug discoverynews2026-02-09T13:00:13+00:00February 9th, 2026|Endpoints News|
Flagship’s Generate:Biomedicines files for IPO, pitching AI-driven drugsnews2026-02-05T12:00:39+00:00February 5th, 2026|Endpoints News|
Menlo and a16z back AI scientist startup Phylonews2026-02-03T12:00:21+00:00February 3rd, 2026|Endpoints News|
Following Abivax, Formation Bio licenses miR-124 drug from Chinanews2026-01-29T12:00:49+00:00January 29th, 2026|Endpoints News|
BioMarin vets spearhead new biotech with $82M for rare disease drugsnews2026-01-22T12:00:19+00:00January 22nd, 2026|Endpoints News|
Teladoc’s mental health arm BetterHelp has quietly expanded the use of AInews2026-01-20T13:00:44+00:00January 20th, 2026|Endpoints News|
